BlackRock’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1M | Buy |
230,505
+13,974
| +6% | +$1.16M | ﹤0.01% | 3015 |
|
|
2025
Q1 | $17.6M | Sell |
216,531
-261,207
| -55% | -$21.2M | ﹤0.01% | 2979 |
|
|
2024
Q4 | $43M | Buy |
477,738
+40,909
| +9% | +$3.68M | ﹤0.01% | 2513 |
|
|
2024
Q3 | $43.2M | Sell |
436,829
-14,582
| -3% | -$1.44M | ﹤0.01% | 2524 |
|
|
2024
Q2 | $41.9M | Sell |
451,411
-40,623
| -8% | -$3.77M | ﹤0.01% | 2492 |
|
|
2024
Q1 | $46.7M | Sell |
492,034
-41,914
| -8% | -$3.98M | ﹤0.01% | 2423 |
|
|
2023
Q4 | $47.7M | Sell |
533,948
-18,044
| -3% | -$1.61M | ﹤0.01% | 2457 |
|
|
2023
Q3 | $40.3M | Sell |
551,992
-11,050
| -2% | -$807K | ﹤0.01% | 2491 |
|
|
2023
Q2 | $46.8M | Sell |
563,042
-22,631
| -4% | -$1.88M | ﹤0.01% | 2479 |
|
|
2023
Q1 | $44.6M | Sell |
585,673
-79,245
| -12% | -$6.04M | ﹤0.01% | 2488 |
|
|
2022
Q4 | $55.2M | Buy |
664,918
+50,970
| +8% | +$4.23M | ﹤0.01% | 2366 |
|
|
2022
Q3 | $48.7M | Buy |
613,948
+142,837
| +30% | +$11.3M | ﹤0.01% | 2428 |
|
|
2022
Q2 | $35M | Buy |
471,111
+467,361
| +12,463% | +$34.7M | ﹤0.01% | 2696 |
|
|
2022
Q1 | $337K | Sell |
3,750
-6
| -0.2% | -$539 | ﹤0.01% | 4892 |
|
|
2021
Q4 | $421K | Buy |
3,756
+6
| +0.2% | +$673 | ﹤0.01% | 4851 |
|
|
2021
Q3 | $471K | Hold |
3,750
| – | – | ﹤0.01% | 4706 |
|
|
2021
Q2 | $508K | Hold |
3,750
| – | – | ﹤0.01% | 4620 |
|
|
2021
Q1 | $509K | Hold |
3,750
| – | – | ﹤0.01% | 4543 |
|
|
2020
Q4 | $528K | Hold |
3,750
| – | – | ﹤0.01% | 4261 |
|
|
2020
Q3 | $418K | Hold |
3,750
| – | – | ﹤0.01% | 4192 |
|
|
2020
Q2 | $420K | Buy |
+3,750
| New | +$420K | ﹤0.01% | 4157 |
|
|
2020
Q1 | – | Sell |
-2
| Closed | – | – | 5000 |
|
|
2019
Q4 | $0 | Sell |
2
-15
| -88% | – | ﹤0.01% | 5007 |
|
|
2019
Q3 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 4896 |
|